SYSKID
Systems biology towards novel chronic kidney disease diagnosis and treatment
| Coordinatore | EMERGENTEC BIODEVELOPMENT GMBH
Organization address
address: GERSTHOFER STRASSE 29-31 contact info |
| Nazionalità Coordinatore | Austria [AT] |
| Sito del progetto | http://www.syskid.eu |
| Totale costo | 15˙743˙594 € |
| EC contributo | 11˙789˙534 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2009-single-stage |
| Funding Scheme | CP-IP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-01-01 - 2014-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
EMERGENTEC BIODEVELOPMENT GMBH
Organization address
address: GERSTHOFER STRASSE 29-31 contact info |
AT (VIENNA) | coordinator | 816˙380.00 |
| 2 |
MEDIZINISCHE UNIVERSITAET INNSBRUCK
Organization address
address: Christoph-Probst Platz 1 contact info |
AT (INNSBRUCK) | participant | 1˙526˙360.00 |
| 3 |
MEDIZINISCHE UNIVERSITAET WIEN
Organization address
address: SPITALGASSE 23 contact info |
AT (WIEN) | participant | 965˙360.00 |
| 4 |
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Organization address
address: Chariteplatz 1 contact info |
DE (BERLIN) | participant | 924˙920.00 |
| 5 |
MOSAIQUES DIAGNOSTICS GMBH
Organization address
address: Mellendorfer Strasse 7-9 contact info |
DE (HANNOVER) | participant | 662˙140.00 |
| 6 |
ACADEMISCH ZIEKENHUIS GRONINGEN
Organization address
address: Hanzeplein 1 contact info |
NL (GRONINGEN) | participant | 620˙120.00 |
| 7 |
WEIZMANN INSTITUTE OF SCIENCE
Organization address
address: HERZL STREET 234 contact info |
IL (REHOVOT) | participant | 506˙716.00 |
| 8 |
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Organization address
address: BELFIELD contact info |
IE (DUBLIN) | participant | 485˙500.00 |
| 9 |
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
Organization address
address: Via Giuseppe La Masa 19 contact info |
IT (MILANO) | participant | 457˙160.00 |
| 10 |
INSTITUT CATALA DE LA SALUT
Organization address
address: GRAN VIA DE LES CORTS CATALANES 587 contact info |
ES (BARCELONA) | participant | 457˙052.00 |
| 11 |
UNIVERSITAET DES SAARLANDES
Organization address
address: CAMPUS contact info |
DE (SAARBRUECKEN) | participant | 455˙720.00 |
| 12 |
Biomarker Design Forschungs GmbH
Organization address
address: Divischgasse 4 contact info |
AT (Vienna) | participant | 446˙800.00 |
| 13 |
Biogazelle
Organization address
address: Kruishoutemstraat 57 contact info |
BE (Zulte) | participant | 417˙060.00 |
| 14 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 385˙160.00 |
| 15 |
Steno Diabetes Center A/S
Organization address
address: Niels Steensens Vej 2 contact info |
DK (Gentofte) | participant | 336˙672.00 |
| 16 |
UNIVERSITATSKLINIKUM ERLANGEN
Organization address
address: Maximiliansplatz 2 contact info |
DE (ERLANGEN) | participant | 336˙160.00 |
| 17 |
BIOCRATES LIFE SCIENCES AG
Organization address
address: EDUARD BODEM GASSE 8 1 STOCK contact info |
AT (Innsbruck) | participant | 288˙120.00 |
| 18 |
UNIVERSITE DE BORDEAUX
Organization address
address: PLACE PEY BERLAND 35 contact info |
FR (BORDEAUX) | participant | 261˙160.00 |
| 19 |
CELERA CORPORATION
Organization address
address: Centerville Road - Suite 400 2711 contact info |
US (WILMINGTON) | participant | 258˙000.00 |
| 20 |
UNIVERSIDAD DE CORDOBA
Organization address
address: AVENIDA DE MEDINA AZAHARA 5 contact info |
ES (CORDOBA) | participant | 226˙800.00 |
| 21 |
CONSIGLIO NAZIONALE DELLE RICERCHE
Organization address
address: Piazzale Aldo Moro 7 contact info |
IT (ROMA) | participant | 186˙614.00 |
| 22 |
?l?ski Uniwersytet Medyczny w Katowicach
Organization address
address: Poniatowskiego 15 contact info |
PL (Katowice) | participant | 166˙240.00 |
| 23 |
SEMMELWEIS EGYETEM
Organization address
address: Ulloi ut 26 contact info |
HU (BUDAPEST) | participant | 166˙240.00 |
| 24 |
UNIVERSITY OF GLASGOW
Organization address
address: University Avenue contact info |
UK (GLASGOW) | participant | 166˙240.00 |
| 25 |
UNIVERSITAETSKLINIKUM AACHEN
Organization address
address: Pauwelsstrasse 30 contact info |
DE (AACHEN) | participant | 125˙640.00 |
| 26 |
ProScience Communications - die Agentur fur Wissenschaftskommunikation GmbH
Organization address
address: Andechser Weg 17 contact info |
DE (Poecking) | participant | 114˙000.00 |
| 27 |
AMGEN (EUROPE) GMBH
Organization address
address: DAMMSTRASSE 23 contact info |
CH (ZUG) | participant | 31˙200.00 |
| 28 |
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE
Organization address
address: AVENIDA GRAN VIA HOSPITALET 199-203 contact info |
ES (L'HOSPITALET DE LLOBREGAT) | participant | 0.00 |
| 29 |
UNIVERSITE VICTOR SEGALEN BORDEAUX II
Organization address
address: RUE LEO SAIGNAT 146 contact info |
FR (BORDEAUX CEDEX) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts the patient’s quality of life by causing serious comorbidities including cardiovascular complications and bone metabolism disorders. On the everyday clinical level early stage diagnosis and tailored treatment of CKD are still inadequate. In addition, CKD seems not to have reached its appropriate emplacement in an epidemiological and healthcare perspective yet, and the pathophysiology of the disease on a molecular and cellular level is not well enough understood. Our sysKID consortium was installed for precisely addressing these issues: To unravel the molecular and cellular mechanisms of chronic kidney disease development, combine this information with clinical risk factors, and on this basis delineate chronic kidney disease biomarkers. These markers will allow us to perform preclinical studies of novel therapy approaches for halting disease progression, and will provide us with the materials for development and clinical evaluation of tools for early stage diagnosis as well as prognosis and treatment monitoring. sysKID assures a successful implementation of these goals by a truly international consortium of 27 leading research groups. We combine clinical know how, provide access to a huge chronic kidney disease sample and clinical data pool, and build a Systems Biology framework for chronic kidney disease by integrating molecular and cellular biology, computational biology, statistics and epidemiology. Our expert group is further complemented by a high level advisory board covering science, product development, and the patient’s perspective. sysKID implementation is structured for completing pre-clinical Proof of Concept studies of novel chronic kidney disease therapy regimes, and further for completing clinical evaluation of an epidemiological screening tool as well as of early stage chronic kidney disease diagnostic kits.'